DexCom (NasdaqGS:DXCM) Shares Dip 1% Despite 7% Sales Growth
DexCom (NasdaqGS:DXCM) recently received a warning letter from the FDA, which pointed out issues in manufacturing processes and quality management. While these regulatory developments did not impact ...
Devdiscourse11 小时
USDA Scraps Food Safety Committees Amid Oversight Concerns
The U.S. Department of Agriculture has dissolved two key food safety advisory committees, sparking concern over government ...
TipRanks on MSN21 小时
DexCom warning letter ‘not thesis changing,’ says BofA
BofA keeps a Buy rating on DexCom (DXCM) with a $105 price target after Dexcom announced it received a warning letter from the FDA. Importantly, ...
TipRanks on MSN21 小时
Wells sees no material impact from DexCom warning letter
Wells Fargo analyst Larry Biegelsen keeps an Overweight rating on DexCom (DXCM) with a $98 price target after the company disclosed that a warning ...